z-logo
open-access-imgOpen Access
Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome
Author(s) -
Guillermo E. Umpierrez,
Mary Beth Murphy,
Abbas E. Kitabchi
Publication year - 2002
Publication title -
diabetes spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.716
H-Index - 31
eISSN - 1944-7353
pISSN - 1040-9165
DOI - 10.2337/diaspect.15.1.28
Subject(s) - medicine , diabetic ketoacidosis , diabetes mellitus , intensive care medicine , ketoacidosis , mortality rate , pediatrics , endocrinology , type 1 diabetes
In Brief Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic syndrome (HHS) are two acute complications of diabetes that can result in increased morbidity and mortality if not efficiently and effectively treated. Mortality rates are 2–5% for DKA and 15% for HHS, and mortality is usually a consequence of the underlying precipitating cause(s) rather than a result of the metabolic changes of hyperglycemia. Effective standardized treatment protocols, as well as prompt identification and treatment of the precipitating cause, are important factors affecting outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom